ENTITY
GlaxoSmithKline PLC

GlaxoSmithKline PLC (GSK LN)

108
Analysis
Health CareUnited Kingdom
GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
16 Mar 2018 10:27

Sector Capsule: Other Hot Drinks in Singapore

Other Hot Drinks retail sales declined by 1% to SGD66 million, and marginally in volume terms to 7,366 tonnes in 2017 Consumer fatigue in the...

Share
13 Dec 2017 17:44

Aussie Healthcare Daily: 12 & 13 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
416 Views
Share
28 Nov 2017 16:52

Drugs Evolving Into 'Biological Software' to Boost Moribund Pharma Sector?

The global pharma and biotech sector has underperformed by about four points this year, and five over three years – the divergence with other...

Logo
227 Views
Share
bullishS&P 500 INDEX
14 Nov 2017 20:39

U.S. Equity Strategy & Individual Sector Commentaries

In our November Macro Vision report, we provide an appraisal and recommendations for each of our 12 Sectors, with extra attention devoted...

Logo
326 Views
Share
08 Nov 2017 20:24

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

Logo
314 Views
Share
x